|
45
|
127
|
3svgA |
Crystal structure of the first bromodomain of human brd4 in complex with a 3,5-dimethylisoxazol ligand |
|
45
|
127
|
3svfA |
Crystal structure of the first bromodomain of human brd4 in complex with a dihydro-quinazolin ligand |
|
37
|
107
|
3s91A |
Crystal structure of the first bromodomain of human brd3 in complex with the inhibitor jq1 |
|
43
|
110
|
3s92A |
Crystal structure of the second bromodomain of human brd3 in complex with the inhibitor jq1 |
|
38
|
117
|
3rcwA |
Crystal structure of the bromodomain of human brd1 |
|
43
|
116
|
5tcmA |
First bromodomain from leishmania donovani ldbpk.091320 complexed with bi-2536 |
|
41
|
119
|
5tb6A |
Structure of bromodomain of crebbp with a pyrazolo[4,3-c]pyridin fragment |
|
42
|
127
|
5cfwA |
Selective pharmacological inhibition of the creb binding protein bromodomain regulates inflammatory cytokines in macrophages and rgs4 in neurons |
|
39
|
116
|
5l97A |
Crystal structure of baz2b bromodomain in complex with 3-amino-2-methylpyridine derivative 3 |
|
41
|
113
|
4z6hA |
Crystal structure of brd9 bromodomain in complex with a valerolactam quinolone ligand |
|
36
|
102
|
4yy6A |
Crystal structure of brd9 bromodomain bound to a butyryllysine peptide |
|
55
|
130
|
5a81A |
Crystal structure of human atad2 bromodomain in complex with 8-(3r,4r) -3-(cyclohexylmethoxy)piperidin-4-yl-amino-3-methyl-1,2-dihydro-1,7- naphthyridin-2-one |
|
35
|
100
|
4yygA |
Crystal structure of brd9 bromodomain bound to a butyryllysine peptide |
|
41
|
116
|
5l98A |
Crystal structure of baz2b bromodomain in complex with 3-amino-2-methylpyridine derivative 4 |
|
45
|
126
|
5a85A |
N-terminal bromodomain of human brd4 with 8-(3r,4r)-3-(cyclohexylmethoxy)piperidin-4-ylamino-3-methyl-1,2-dihydro-1,7- naphthyridin-2-one |
|
40
|
116
|
5l96A |
Crystal structure of baz2b bromodomain in complex with 3-amino-2-methylpyridine derivative 1 |
|
55
|
130
|
5a83A |
Crystal structure of human atad2 bromodomain in complex with 4-((3r, 4r)-4-3-methyl-5-(5-methylpyridin-3-yl)-2-oxo-1,2-dihydroquinolin-8- yl-aminopiperidin-3-yloxymethyl)-1-thiane-1,1-dione |
|
37
|
107
|
5ktuA |
Crystal structure of the bromodomain of human crebbp bound to pyrazolopiperidine scaffold |
|
43
|
126
|
5khmA |
The first bet bromodomain of brd4 bound to compound 13 in a bivalent manner |
|
55
|
130
|
5a5nA |
Crystal structure of human atad2 bromodomain in complex with (2s)-2,6- diacetamido-n-methylhexanamide |
|
36
|
101
|
5i7xA |
Brd9 in complex with cpd2 (n,n-dimethyl-3-(6-methyl-7-oxo-6,7-dihydro-1h-pyrrolo[2,3-c]pyridin-4-yl)benzamide) |
|
42
|
111
|
5ibnA |
Ultra high resolution crystal structure of the apo- form of second bromodomain of brd2. |
|
44
|
115
|
5ig6A |
Ultra-high resolution crystal structure of second bromodomain of brd2 in complex with inhibitor 6b3 |
|
41
|
110
|
5hjcA |
Brd3 second bromodomain in complex with histone h3 acetylation at k18 |
|
36
|
112
|
5ii1A |
Crystal structure of the fifth bromodomain of human polybromo (pb1) in complex with 1-methylisochromeno[3,4-c]pyrazol-5(3h)-one |
|
41
|
110
|
5hfrA |
Crystal structure of the second bromodomain h395r mutant of human brd3 |
|
40
|
118
|
5h85A |
Crystal structure of the bromodomain of human crebbp in complex with uo37d |
|
37
|
115
|
5ii2A |
Crystal structure of the fifth bromodomain of human polybromo (pb1) in complex with 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4h-chromen-4-one |
|
42
|
125
|
5hq7A |
Crystal structure of fragment bound with brd4 |
|
41
|
109
|
5hfqA |
Crystal structure of the second bromodomain q443h mutant of human brd2 |
|
39
|
119
|
5helA |
Crystal structure of the n-terminus y153h bromodomain mutant of human brd2 |
|
39
|
115
|
5hrvA |
Crystal structure of the fifth bromodomain of human pb1 in complex with 1-ethylisochromeno[3,4-c]pyrazol-5(2h)-one) compound |
|
40
|
121
|
5hemA |
Crystal structure of the n-terminus d161y bromodomain mutant of human brd2 |
|
41
|
115
|
5i89A |
Crystal structure of the bromodomain of human crebbp bound to the benzodiazepinone g02857790 |
|
37
|
109
|
5henA |
Crystal structure of the n-terminus r100l bromodomain mutant of human brd2 |
|
39
|
109
|
5g4rA |
Bromodomain of human brpf1 with n-1,3-dimethyl-6-2r-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1h-1,3-benzodiazol-5-yl-2- methoxybenzamide |
|
39
|
124
|
4zw1A |
Crystal structure of hbrd4 in complex with bl-bi06 reveals a novel synthesized inhibitor that induces beclin1-independent/atg5-dependent autophagic cell death in breast cancer |
|
38
|
116
|
5g4sA |
Bromodomain of human brpf1 with n-1,3-dimethyl-6-2r-2- methylpiperazin-1-yl-2-oxo-2,3-dihydro-1h-1,3-benzodiazol-5-yl-n- ethyl-2-methoxybenzamide |
|
41
|
127
|
4zc9A |
Crystal structure of the brd4a/db-2-190 complex |
|
50
|
182
|
5h1vA |
Complex structure of trim24 phd-bromodomain and inhibitor 6 |
|
42
|
112
|
5fh8A |
Crystal structure of the fifth bromodomain of human pb1 in complex with compound 28 |
|
42
|
127
|
5fbxA |
Crystal structure of the first bromodomain of human brd4 in complex with pnz5 isoxazole inhibitor |
|
43
|
127
|
5f60A |
Crystal structure of the first bromodomain of human brd4 in complex with sg3-014 |
|
35
|
111
|
5fh6A |
Crystal structure of the fifth bromodomain of human pb1 in complex with compound 10 |
|
38
|
110
|
5ffwA |
Crystal structure of the bromodomain of human brpf1 in complex with h4k5ack8ac histone peptide |
|
57
|
178
|
5fb1A |
Crystal structure of a phd finger bound to histone h3 k9me3 peptide |
|
40
|
127
|
5f5zA |
Crystal structure of the first bromodomain of human brd4 in complex with ma2-014 |
|
40
|
115
|
5fh7A |
Crystal structure of the fifth bromodomain of human pb1 in complex with compound 18 |
|
41
|
108
|
5fe4A |
Crystal structure of human pcaf bromodomain in complex with fragment mb364 (fragment 5) |
|
41
|
109
|
5fe3A |
Crystal structure of human pcaf bromodomain in complex with fragment mb360 (fragment 4) |
